Aeterna acquires Zentaris

Aeterna (TSE:AEL; AELA) acquired cancer company Zentaris (Frankfurt, Germany) for C$81.5 million (US$51.9 million). AEL said Zentaris adds to its pipeline of oncology products. In the area of cancer, ...